| 000 | 03667nam a22004095i 4500 | ||
|---|---|---|---|
| 999 |
_c383716 _d383716 |
||
| 001 | 383716 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102122144.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 201205s2021 sz | s |||| 0|eng d | ||
| 020 | _a9783030620806 | ||
| 024 | 7 |
_a10.1007/978-3-030-62080-6 _2doi |
|
| 040 |
_bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRM301.3 .G45 _b2021 EB |
|
| 100 |
_aJain, Kewal K. _eautor _984949 |
||
| 245 | 1 | 0 |
_aTextbook of Personalized Medicine _cby Kewal K. Jain |
| 250 | _a3rd edition 2021 | ||
| 264 | 1 |
_aCham _bSpringer International Publishing _c2021 |
|
| 300 |
_a1 recurso en línea (XLIII, 744 páginas) _b41 ilustraciones, 5 ilustraciones a color |
||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_aarchivo de texto _bPDF |
||
| 505 | 0 | _aBasic Aspects -- Molecular Diagnostics in Personalized Medicine -- Role of Biomarkers in Personalized Medicine -- Pharmacogenetics -- Pharmacogenomics -- Role of Pharmacoproteomics -- Role of Metabolomics in Personalized Medicine -- Role of Nanobiotechnology in Development of Personalized Medicine -- Personalized Biological Therapies -- Personalized Non-pharmacological Therapies -- Personalized Therapy of Cancer -- Personalized Therapy of Neurological Disorders -- Personalized Therapy of Psychiatric Disorders -- Personalized Therapy of Cardiovascular Disorders -- Personalized Therapy of Pulmonary Disorders -- Personalized Therapy Infectious Diseases -- Personalized Approaches in Immunology -- Personalized Management of Genetic Disorders -- Personalized Management of Miscellaneous Disorders -- Development of Personalized Medicine -- Ethical Aspects of Personalized Medicine -- Legal Aspects of Personalized Medicine -- Regulatory Aspects of Personalized Medicine -- Economics of Personalized Medicine -- Future of Personalized Medicine. | |
| 520 | 3 | _aThis book is for personalized medicine as a prescription of specific treatments and therapeutics best suited for an individual and considersgenetic as well as environmental factors that influence responses to therapy. Best approaches are described for integration of all available technologies for optimizing the therapy of individual patients. This comprehensive third edition covers the latest advances in personalized medicine and several chapters are devoted to various specialties, particulary cancer which is the largest area of application. The book discusses the development of personalized medicine and various playersin it such as companies, academic institutions, the government, and the public as the consumer of healthcare. Additionally, the roles of bioinformatics, electronic health records, and digital technologies for personalized medicine are discussed. Textbook of Personalized Medicine, 3rd Edition serves as a convenient source of information for students at many levels and in a wide range of fields, including physicians, scientists, and decision makers in the biopharmaceutical and healthcare industries. | |
| 988 | _aSpringer_Medicine_2021 | ||
| 650 | 7 |
_2embne _9165192 _aFarmacogenómica |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9783030620790 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030620813 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030620820 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-62080-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b11/2022 _dz _eu _zSI |
||